Floatz logo

Therapeutic Asset Ratings

6,308 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
sar443579
Acute Lymphoblastic Leukemia
SanofiP1/2CCC (48)
Sarcoma-Specific Car-T Cells
Osteosarcoma
Shenzhen Geno-Immune Medical InstituteP1/2CCC (48)
Sargramostim
Gastroesophageal Junction Adenocarcinoma
Mayo ClinicP1/2CCC (48)
Sargramostim
Cutaneous Neuroendocrine Carcinoma
Mayo ClinicP1/2CCC (48)
Sargramostim
Cervical Carcinoma
Mayo ClinicP1/2CCC (48)
Sargramostim
Head And Neck Squamous Cell Carcinoma
Mayo ClinicP1/2CCC (48)
Sargramostim
Hepatocellular Carcinoma
Mayo ClinicP1/2CCC (48)
Sargramostim
Renal Cell Carcinoma
Mayo ClinicP1/2CCC (48)
Sargramostim
Skin Squamous Cell Carcinoma
Mayo ClinicP1/2CCC (48)
Sargramostim
Urothelial Carcinoma
Mayo ClinicP1/2CCC (48)
Sargramostim
Uterine Corpus Cancer
Mayo ClinicP1/2CCC (48)
Sargramostim
Uterine Corpus Endometrial Carcinoma
Mayo ClinicP1/2CCC (48)
Sargramostim
Head And Neck Neoplasm
Mayo ClinicP1/2CCC (48)
Sarilumab
Breast Disorder
University of Southern CaliforniaP1/2CCC (48)
Sarilumab
Ovarian Serous Adenocarcinoma
Regeneron PharmaceuticalsP1/2CCC (48)
Sarilumab
Endometrial Cancer
Regeneron PharmaceuticalsP1/2CCC (48)
Saruparib
Biliary Tract Cancer
AstraZenecaP1/2CCC (48)
sb-913
Mucopolysaccharidosis Type 2
Sangamo TherapeuticsP1/2CCC (48)
sc0191
Ovarian Serous Adenocarcinoma
Biocity Biopharmaceutics Co., Ltd.P1/2CCC (48)
scg142
Cervical Squamous Cell Carcinoma
SCG Cell Therapy Pte. Ltd.P1/2CCC (48)
scg142
Head And Neck Cancer
SCG Cell Therapy Pte. Ltd.P1/2CCC (48)
scg142
Human Papillomavirus-Related Squamous Cell Carcinoma
SCG Cell Therapy Pte. Ltd.P1/2CCC (48)
scg142
Vaginal Squamous Cell Carcinoma
SCG Cell Therapy Pte. Ltd.P1/2CCC (48)
Selinexor
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly
Sun Yat-sen UniversityP1/2CCC (48)
Selinexor
MALT Lymphoma
Barbara Ann Karmanos Cancer InstituteP1/2CCC (48)
Showing 1776 to 1800 of 6,308 assets
PreviousPage 72 of 253Next